Plain-English translation of NCT06650956 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether combining HPV vaccination (a single-dose vaccine that protects against certain types of human papillomavirus) with broader adolescent health education and services helps more young people in Laos get vaccinated and learn about sexual and reproductive health. The study will compare two approaches: one district will offer the vaccine alongside comprehensive health education in schools, clinics, and community outreach, while another district will offer routine vaccination only. Researchers want to see if this integrated approach works better and is cost-effective.
HPV vaccination rates in Laos are lower than they should be to protect young people from certain cancers and infections. This trial explores whether bundling the vaccine with broader health education and services—especially for teens who are out of school or in remote areas—could increase vaccination rates and improve overall adolescent health in ways that are sustainable and fair.
You likely qualify if…
You likely don't qualify if…
If you are in the intervention district, you may receive the HPV vaccine and participate in sexual and reproductive health education at your school, a health facility, or through community outreach visits. If you are in the comparison district, you will receive the standard HPV vaccination campaign. Over 9 months, researchers will track whether and when you get vaccinated, and they may ask you and your caregivers questions about your knowledge, attitudes, and use of health services.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Laos